Seth J Concors

Oct 11, 2024 | digitalcommons.library.tmc.edu | Neal Bhutiani |Travis E. Grotz |Michael White |Seth J Concors

INTRODUCTION: Many patients with mucinous appendiceal adenocarcinoma experience peritoneal recurrence despite complete cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Prior work has demonstrated that repeat CRS/HIPEC can prolong survival in select patients. We sought to validate these findings using outcomes from a high-volume center.